Reply to recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy [2]

Katsuyuki Hotta, Yoshiro Fujiwara, Keitaro Matsuo

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'Reply to recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy [2]'. Together they form a unique fingerprint.